Research/art/teacher profile of a person

Name and surname:	PharmDr. Miroslava Potúčková, PhD.
Document type:	Research/art/teacher profile of a person
The name of the university:	Comenius University Bratislava
The seat of the university:	Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname

Potúčková

I.2 - Name

Miroslava

I.3 - Degrees

PharmDr., PhD.

I.4 - Year of birth

1981

I.5 - Name of the workplace

Faculty of Pharmacy of Commenius University

I.6 - Address of the workplace

Odbojárov 10, 832 32 Bratislava

I.7 - Position

professor - assistant

I.8 - E-mail address

miroslava.potuckova@fpharm.uniba.sk

I.10 - Name of the study field in which a person works at the university

Pharmaceutical technology

I.11 - ORCID iD

0000-0002-7055-0388

II. - Higher education and further qualification growth

II.1 - First degree of higher education

II.a - Name of the university or institution

Faculty of Pharmacy of Comenius University

II.b - Year

2004

II.c - Study field and programme

Pharmacy

II.2 - Second degree of higher education

II.a - Name of the university or institution

Faculty of Pharmacy of Comenius University

II.b - Year

2005

II.c - Study field and programme

Radionuclide analysis

II.3 - Third degree of higher education

II.a - Name of the university or institution

Faculty of Pharmacy of Comenius University

II.b - Year

2010

II.c - Study field and programme

galenic pharmacy

II.4 - Associate professor

II.5 - Professor

II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position	III.b - Institution	III.c - Duration
assistant, PhD. student	Faculty of pharmacy	2004-2010
professor - assistant	Faculty of pharmacy	2010-2012
pharmacist	pharmacy	2005-2007
professor - assistant	Faculty of pharmacy	2022-2026

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other	IV.b - Name of the institution	IV.c - Year
Word	Commenius University	2023
Excel	Commenius University	2024
Copilot	Commenius University	2025

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes

V.1.a - Name of the profile course	V.1.b - Study programme	V.1.c - Degree	V.1.d - Field of study
Pharmaceutical technology 1	Master study Pharmacy	I.+II.
Pharmaceutical technology 2	Master study Pharmacy	I.+II.

V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year

V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year

V.4 - Overview of supervised final theses

V.4.1 - Number of currently supervised theses

V.4.b - Diploma (second degree)

2

V.4.2 - Number of defended theses

V.4.a - Bachelor's (first degree)

1

V.4.b - Diploma (second degree)

3

V.5 - Overview of other courses taught in the current academic year according to study programmes

V.5.a - Name of the course	V.5.b - Study programme	V.5.c - Degree	V.5.d - Field of study
Cosmetics in Pharmacy	Master study Pharmacy	I.+II.
Good Manufacturing Drugs Practice	Master study Pharmacy	I.+II.

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations

VI.1.1 - Number of the research/artistic/other outputs

VI.1.a - Overall

42

VI.1.b - Over the last six years

4

VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases

VI.1.a - Overall

7

VI.1.b - Over the last six years

1

VI.1.3 - Number of citations corresponding to the research/artistic/other outputs

VI.1.a - Overall

16

VI.1.b - Over the last six years

6

VI.1.4 - Number of citations registered in the Web of Science or Scopus databases

VI.1.a - Overall

16

VI.1.b - Over the last six years

6

VI.1.5 - Number of invited lectures at the international, national level

VI.1.a - Overall

1

VI.1.b - Over the last six years

1

VI.2 - The most significant research/artistic/other outputs

1

Indomethacin release in relation to the concentration of pharmaceutical excipients

Potúčková, M., Vitková, Z., Tichý, E., Šimunková, V.

Pharmazie

this link is disabled

, 2008, 63(6), pp. 485–486

2

Permeation of indomethacin from semisolid preparations through various semipermeable membranes.

Tichý, E., Žabka, M., Broska, K., ...Šimunková, V., Halenárová, A.

Drug Development and Industrial Pharmacy

this link is disabled

, 2013, 39(9), pp. 1273–1276

3

Possible effects on the liberation of alaptid from dermal semisolid preparations | Možnosti ovplyvnenia liberácie alaptidu z dermálnych polotuhých liekov

Šimunková, V., Vitková, Z., Potúčková, M., Tichý, E.

Ceska a Slovenska Farmacie

this link is disabled

, 2008, 57(6), pp. 275–277

4

Dissolution and spectrophotometric determination of astaxanthin in aqueous solutions

Tichý, E., Žabka, M., Gardavská, K., ...Kontšeková Scheerová, Z., Potúčková, M.

Pharmazie

this link is disabled

, 2011, 66(8), pp. 560–563

5

Formulation Options for Mucoadhesive Dosage Forms for Use in the Oral Cavity.

Šimunková, V., Tichý, E., Špaglová, M., Potúčková, M.

European Pharmaceutical Journal, Issue 70, č. S1 (2023), s. 44-51

6

eterinary eye drops with a biological component

Potúčková, Miroslava ; Matušová, Desana ; Raučinová, Mária ; Valachová, Zuzan] ; Kubeš, Miroslav

European pharmaceutical journal

Eur. Pharm. J. 2025, 72(s2), 1-54.ISSN 1338-6786 (online) and ISSN 2453-6725 (print version),DOI: 10.2478/afpuc-2025-0009

VI.3 - The most significant research/artistic/other outputs over the last six years

1

Formulation Options for Mucoadhesive Dosage Forms for Use in the Oral CavityV. Šimunková, E. Tichý, M. Špaglová and M. PotúčkováEuropean Pharmaceutical JournalPublished Online: 13 Sep 2023Volume & Issue: AHEAD OF PRINTPage range: -Received: 22 Jun 2023Accepted: 23 Jun 2023DOI: https://doi.org/10.2478/afpuc-2023-0012

VI.4 - The most significant citations corresponding to the research/artistic/other outputs

1

Possibilities of the microemulsion use as indomethacin solubilizer and its effect on in vitro and ex vivo drug permeation from dermal gels in comparison with transcutol®

Špaglová, M., Čuchorová, M., Šimunková, V., (...), Starýchová, L., Bauerová, K.

2020

Drug Development and Industrial Pharmacy

2

Preparation, optimization using a mixture design, and characterization of a novel astaxanthin-loaded rice bran oil self-microemulsifying delivery system formulation

Aung, W.T., Boonkanokwong, V.

2023

Journal of Dispersion Science and Technology

3

Microencapsulation of lutein extracted from marigold flowers (Tagetes erecta L.) using full factorial design

Nalawade, P.B., Gajjar, A.K.

2016

Journal of Drug Delivery Science and Technology

4

Development and optimisation of biopharmaceutical properties of a new microemulgel of cannabidiol for locally-acting dermatological delivery

Vanti, G., Grifoni, L., Bergonzi, M.C., (...), Caproni, M., Bilia, A.R.

2021

International Journal of Pharmaceutics

5

Dissolution and spectrophotometric determination of astaxanthin in aqueous solutions

Tichý, E., Žabka, M., Gardavská, K., ... Kontšeková Scheerová, Z., Potúčková, M.

PharmazieOpen source preview, 2011, 66(8), pp. 560–563

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years

1

KEGA 041UK-4/2024

Implementation of new research findings and innovative teaching methods in the subject of pharmaceutical technology

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VII.a - Activity, position	VII.b - Name of the institution, board	VII.c - Duration
member of the committee for the Technology Days 2025 conference	40th Technology days	2025

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

IX. - Other relevant facts

Date of last update

2026-02-24